Literature DB >> 18032509

Mouse mammary tumor virus integration site selection in human and mouse genomes.

Alexander Faschinger1, Francoise Rouault, Johannes Sollner, Arno Lukas, Brian Salmons, Walter H Günzburg, Stanislav Indik.   

Abstract

Based on integration site preferences, retroviruses can be placed into three groups. Viruses that comprise the first group, murine leukemia virus and foamy virus, integrate preferentially near transcription start sites. The second group, notably human immunodeficiency virus and simian immunodeficiency virus, preferentially targets transcription units. Avian sarcoma-leukosis virus (ASLV) and human T-cell leukemia virus (HTLV), forming the third group, show little preference for any genomic feature. We have previously shown that some human cells sustain mouse mammary tumor virus (MMTV) infection; therefore, we infected a susceptible human breast cell line, Hs578T, and, without introducing a species-specific bias, compared the MMTV integration profile to those of other retroviruses. Additionally, we infected a mouse cell line, NMuMG, and thus we could compare MMTV integration site selection in human and mouse cells. In total, we examined 468 unique MMTV integration sites. Irrespective of whether human or mouse cells were infected, no integration bias favoring transcription start sites was detected, a profile that is reminiscent of that of ASLV and HTLV. However, in contrast to ASLV and HTLV, not even a modest tendency in favor of integration within genes was observed. Similarly, repetitive sequences and genes that are frequently tagged by MMTV in mammary tumors were not preferentially targeted in cell culture either in mouse or in human cells; hence, we conclude that MMTV displays the most random dispersion of integration sites among retroviruses determined so far.

Entities:  

Mesh:

Year:  2007        PMID: 18032509      PMCID: PMC2224419          DOI: 10.1128/JVI.02098-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Retroviral integration and human gene therapy.

Authors:  Frederic D Bushman
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

2.  Integration targeting by avian sarcoma-leukosis virus and human immunodeficiency virus in the chicken genome.

Authors:  Stephen D Barr; Jeremy Leipzig; Paul Shinn; Joe R Ecker; Frederic D Bushman
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

3.  Protection of retroviral DNA from autointegration: involvement of a cellular factor.

Authors:  M S Lee; R Craigie
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

4.  Human T-cell leukemia virus type 1 integration target sites in the human genome: comparison with those of other retroviruses.

Authors:  David Derse; Bruce Crise; Yuan Li; Gerald Princler; Nicole Lum; Claudia Stewart; Connor F McGrath; Stephen H Hughes; David J Munroe; Xiaolin Wu
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

5.  Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome.

Authors:  R Nusse; H E Varmus
Journal:  Cell       Date:  1982-11       Impact factor: 41.582

Review 6.  BAF: roles in chromatin, nuclear structure and retrovirus integration.

Authors:  Miriam Segura-Totten; Katherine L Wilson
Journal:  Trends Cell Biol       Date:  2004-05       Impact factor: 20.808

7.  Fgf10 is an oncogene activated by MMTV insertional mutagenesis in mouse mammary tumors and overexpressed in a subset of human breast carcinomas.

Authors:  Vassiliki Theodorou; Mandy Boer; Britta Weigelt; Jos Jonkers; Martin van der Valk; John Hilkens
Journal:  Oncogene       Date:  2004-08-12       Impact factor: 9.867

8.  Integration of type B retroviral DNA in virus-induced primary murine thymic lymphomas.

Authors:  G A Dekaban; J K Ball
Journal:  J Virol       Date:  1984-12       Impact factor: 5.103

9.  LEDGF/p75 determines cellular trafficking of diverse lentiviral but not murine oncoretroviral integrase proteins and is a component of functional lentiviral preintegration complexes.

Authors:  Manuel Llano; Maria Vanegas; Oliver Fregoso; Dyana Saenz; Susan Chung; Mary Peretz; Eric M Poeschla
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

10.  Transcription start regions in the human genome are favored targets for MLV integration.

Authors:  Xiaolin Wu; Yuan Li; Bruce Crise; Shawn M Burgess
Journal:  Science       Date:  2003-06-13       Impact factor: 47.728

View more
  48 in total

Review 1.  Integrase, LEDGF/p75 and HIV replication.

Authors:  E M Poeschla
Journal:  Cell Mol Life Sci       Date:  2008-05       Impact factor: 9.261

Review 2.  Integration site selection by retroviral vectors: molecular mechanism and clinical consequences.

Authors:  René Daniel; Johanna A Smith
Journal:  Hum Gene Ther       Date:  2008-06       Impact factor: 5.695

3.  Proviruses selected for high and stable expression of transduced genes accumulate in broadly transcribed genome areas.

Authors:  Jirí Plachy; Jan Kotáb; Petr Divina; Markéta Reinisová; Filip Senigl; Jirí Hejnar
Journal:  J Virol       Date:  2010-02-10       Impact factor: 5.103

4.  Key determinants of target DNA recognition by retroviral intasomes.

Authors:  Erik Serrao; Allison Ballandras-Colas; Peter Cherepanov; Goedele N Maertens; Alan N Engelman
Journal:  Retrovirology       Date:  2015-04-30       Impact factor: 4.602

Review 5.  MMTV infectious cycle and the contribution of virus-encoded proteins to transformation of mammary tissue.

Authors:  Susan R Ross
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-07-26       Impact factor: 2.673

6.  Mouse mammary tumor virus-like virus infection and the risk of human breast cancer: a meta-analysis.

Authors:  Faliang Wang; Jinchao Hou; Qi Shen; Yongfang Yue; Fajun Xie; Xian Wang; Hongchuan Jin
Journal:  Am J Transl Res       Date:  2014-05-15       Impact factor: 4.060

7.  Integration target site selection by a resurrected human endogenous retrovirus.

Authors:  Troy Brady; Young Nam Lee; Keshet Ronen; Nirav Malani; Charles C Berry; Paul D Bieniasz; Frederic D Bushman
Journal:  Genes Dev       Date:  2009-03-01       Impact factor: 11.361

8.  Integration site preference of xenotropic murine leukemia virus-related virus, a new human retrovirus associated with prostate cancer.

Authors:  Sanggu Kim; Namshin Kim; Beihua Dong; David Boren; Serena A Lee; Jaydip Das Gupta; Christina Gaughan; Eric A Klein; Christopher Lee; Robert H Silverman; Samson A Chow
Journal:  J Virol       Date:  2008-08-06       Impact factor: 5.103

9.  Identification and characterization of PWWP domain residues critical for LEDGF/p75 chromatin binding and human immunodeficiency virus type 1 infectivity.

Authors:  Ming-Chieh Shun; Yaïr Botbol; Xiang Li; Francesca Di Nunzio; Janet E Daigle; Nan Yan; Judy Lieberman; Marc Lavigne; Alan Engelman
Journal:  J Virol       Date:  2008-09-17       Impact factor: 5.103

10.  Transcription factor binding sites are genetic determinants of retroviral integration in the human genome.

Authors:  Barbara Felice; Claudia Cattoglio; Davide Cittaro; Anna Testa; Annarita Miccio; Giuliana Ferrari; Lucilla Luzi; Alessandra Recchia; Fulvio Mavilio
Journal:  PLoS One       Date:  2009-02-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.